1Meissner HC,Leung DY.Superantigens,conventional antigens and the etiology of Kawasaki syndrome[J].Pediatr Infect Dis,2000,19(2):91-94.
2Iemure M,Ishii M,Sugimura T,et al.Long consequences of regressed coronary aneurysms after Kawasaki disease:Vascular wall morphology and function[J].Heart,2000,83(3):307-311.
3Brogan PA,Shan V,Klein N,et al.Vbeta-restricted T cell adherence to endothelial cells:Α mechanism for superantigen-dependent vascular injury[J].Arthritis Rheum,2004,50(2):589-597.
4Onouchi Y,Onoue S,Tamari M,et al.CD40 ligand gen and Kawasaki disease[J].Eur J Hum Genet,2004,12(12):1062-1068.
5Okada Y,Shinohara M,Kobayashi T,et al.Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children[J].J Pediatr,2003,143(3):363-367.
6Chang RK.Epidemiologic characteristics of children hospitalized for Kawasaki disease in California[J].Pediatr Infect Dis J,2002,21(12):1150-1155.
7Holman RC,Shahriari A,Effler PV,et al.Kawasaki syndrome hospitalizations among children in Hawaii and Connecticut[J].Arch Pediatr Adolesc Med,2000,154(8):804-808.
8Genizi J,Miron D,Spiegel R,et al.Kawasaki disease in very young infants:High prevalence of atypical presentation and coronary arteritis[J].Clin Pediatr(Phila),2003,42(3):263-267.
9Chua PK,Melish ME,Yu Q,et al.Elevated levels of metalloproteinases 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease[J].Clin Diagn Lab Immunol,2003,10(2):308-314.
